Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
Interactions between sialylated glycans and sialic acid-binding immunoglobulin-like lectin (Siglec) receptors have been recently described as potential new immune checkpoint that can be targeted to improve anticancer immunity. Myeloid cells have been reported to express a wide range of different Sig...
Main Authors: | Jinyu Wang, Michela Manni, Anne Bärenwaldt, Ronja Wieboldt, Nicole Kirchhammer, Robert Ivanek, Michal Stanczak, Alfred Zippelius, David König, Natalia Rodrigues Manutano, Heinz Läubli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.828916/full |
Similar Items
-
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
by: Benjamin Müller, et al.
Published: (2023-04-01) -
Pembrolizumab-induced optic neuropathy – a case report
by: Eveline Daetwyler, et al.
Published: (2023-05-01) -
Corrigendum: "Involvement of a Non-human Sialic Acid in Human Cancer"
by: Annie Nithya Samraj, et al.
Published: (2014-04-01) -
Involvement of a Non-Human Sialic Acid in Human Cancer
by: Annie eSamraj, et al.
Published: (2014-02-01) -
Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen
by: Rui-Jun Eveline Li, et al.
Published: (2019-10-01)